Working cross-functionally with Procedure Development, Medical Affairs, Clinical, Marketing, Commercial, Regulatory, and physician subject matter experts, this leader ensures learning solutions are clinically accurate, evidence-based, and aligned with evolving procedural best practices, product innovations, and organizational objectives. In addition to its current liver tumor indication, HistoSonics is pursuing future indications across multiple applications including kidney, pancreas, prostate, neuro, women's health, and other significant underserved human health areas, to realize the broader potential histotripsy across multiple disease states and medical specialties.